0HI7 Stock Overview
Develops, markets, and sells software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
MeVis Medical Solutions AG Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €24.80 |
52 Week High | €25.60 |
52 Week Low | €24.60 |
Beta | 0.0019 |
11 Month Change | n/a |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 15.35% |
Recent News & Updates
Recent updates
Shareholder Returns
0HI7 | GB Healthcare Services | GB Market | |
---|---|---|---|
7D | 0.8% | -3.1% | 0.7% |
1Y | n/a | 23.5% | 6.1% |
Return vs Industry: Insufficient data to determine how 0HI7 performed against the UK Healthcare Services industry.
Return vs Market: Insufficient data to determine how 0HI7 performed against the UK Market.
Price Volatility
0HI7 volatility | |
---|---|
0HI7 Average Weekly Movement | n/a |
Healthcare Services Industry Average Movement | 6.2% |
Market Average Movement | 4.7% |
10% most volatile stocks in GB Market | 10.4% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0HI7's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine 0HI7's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1997 | 116 | Marcus Kirchhoff | www.mevis.de |
MeVis Medical Solutions AG develops, markets, and sells software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company's clinical focuses are image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It offers X-ray based radiography procedures, including computed tomography, mammography/digital tomosynthesis, magnetic resonance imaging, and digital sonography; and provides services in the field of software programming for medical technology companies, which comprise provision of software developers, product and project managers, application specialists, and test engineers.
MeVis Medical Solutions AG Fundamentals Summary
0HI7 fundamental statistics | |
---|---|
Market cap | €45.14m |
Earnings (TTM) | €5.75m |
Revenue (TTM) | €17.64m |
7.8x
P/E Ratio2.6x
P/S RatioIs 0HI7 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0HI7 income statement (TTM) | |
---|---|
Revenue | €17.64m |
Cost of Revenue | €10.72m |
Gross Profit | €6.93m |
Other Expenses | €1.18m |
Earnings | €5.75m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jan 30, 2025
Earnings per share (EPS) | 3.16 |
Gross Margin | 39.27% |
Net Profit Margin | 32.60% |
Debt/Equity Ratio | 0% |
How did 0HI7 perform over the long term?
See historical performance and comparison